Injeq Revenue and Competitors
Estimated Revenue & Valuation
- Injeq's estimated annual revenue is currently $2.1M per year.
- Injeq's estimated revenue per employee is $98,000
Employee Data
- Injeq has 21 Employees.
- Injeq grew their employee count by -9% last year.
Injeq's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Clinical Application Specialist | Reveal Email/Phone |
Injeq Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Injeq?
Injeq Oy (Ltd) is a medtech company devoted to development of tissue identifying products.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$2.1M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Injeq News
2022-04-17 - Tamperelainen älyneulayritys Injeq oy tähyää jo Euroopan ...
Älyneulaa valmistavan tamperelaisen Injeq oy:n myyntijohtaja Seppo Lautamäki (vas.) ja tutkimusinsinööri Juho Kari esittelivät älyneulan toimintaa yrityksen...
2022-04-17 - Bioimpedance spinal needle provides high success and low ...
The bioimpedance spinal needle system (Injeq IQ-Tip system, Injeq Oy, Tampere, Finland, www.injeq.com) comprises either 40 mm, 65 mm,...
2022-03-30 - Mitä tehdä, kun pörssiaikeet kaatuvat yhdessä yössä ...
Kasvuaikeita korostava Injeq aikoi kerätä First North -listautumisella 8,0 miljoonaa euroa, mutta sota Ukrainassa sotki sen suunnitelmat.
Other Companies in Tampere
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | -9% | N/A |
#2 | $5.4M | 22 | 5% | N/A |
#3 | $2.2M | 22 | -24% | N/A |
#4 | $4M | 26 | -21% | N/A |
#5 | $6.4M | 26 | 0% | N/A |